Revive Therapeutics part of first psychedelic exchange traded fund
Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) (FRA:31R) revealed Friday that the specialty life sciences company is one of the 17 companies in the US and Canada that will be included in the first psychedelics exchange traded fund managed by Horizons ETF Management.
The Horizons Psychedelic Stock Index ETF index is expected to start trading on January 26, under the ticker PSYK on the NEO exchange.
“We are pleased to be included in the First Psychedelics ETF and being recognized as a leading company in the field of psychedelic pharmaceuticals,” said Revive CEO Michael Frank.
Investors responded well, sending shares nearly 10.2% higher to US$0.47 on the OTC Markets.
READ: Revive Therapeutic inks non-binding LOI to buy PharmaTher Inc psilocybin intellectual property
“We are advancing novel psilocybin-based therapeutics using a proprietary oral thin film delivery technology and a natural biosynthesis enzymatic platform to support clinical research in mental health and substance abuse disorders.”
Revive is advancing its psychedelic pharmaceuticals pipeline by collaborating on an oral thin film product with the University of Wisconsin-Madison and a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform developed by Dr Gavin Williams, a professor and researcher at North Carolina State University.
It is also engaged in a clinical study with the University of Wisconsin evaluating psilocybin in the treatment of methamphetamine use disorder, and research with psilocybin being done by PharmaTher Inc (CSE:PHRM) (OTCQB:PHRRF).
With its recent acquisition of Psilocin Pharma Corp, Revive is advancing the development of psilocybin-based therapeutics in various diseases. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
Contact the author Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/939296/revive-therapeutics-part-of-first-psychedelic-exchange-traded-fund-939296.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper -
Bioavailable Copper
destroys
pathogens and gives you more
energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans
out
toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification,
mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter
radiation by 96%! (See Video)
Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.
| Online: | |
| Visits: | 1,219,747,705 |
| Stories: | 7,436,345 |
Whistler Blowers, Insiders
